Tissue Collection for Patients with Cancers other than Hepatobilairy Cancers with Metastasis to the Liver
About this study
The goal of this study is to develop a resource (bank) of biospecimens (blood, tissue) from patients having cancers that metastasis to the liver. The purpose of the resource bank is to facilitate studies on the pathogenesis of cancers metastasizing to the liver and also in order to assess the ability of new tests to detect early cancer in the cohort of patients undergoing routine surveillance for cancer. The biospecimens will include cultures of tumor cells and tumor-associated non-malignant cells, as well as xenografts established from freshly isolated metastatic cancers in immunodeficient mice. We plan to administer a risk factor questionnaire to facilitate identification of risk factors for development of metastatic liver cancer. The study will also determine survival of patients from time of diagnosis.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- 18 years and older
- Diagnosed with cancer
- Consent to undergo percutaneous ultrasound or CT guided biopsies and allow us to obtain additional biopsy cores of tissue for research purposes only.
- Does not have cancer diagnosis
- Medical contraindication to percutaneous ultrasound or CT guided biopsies
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
Publications are currently not available
Study Results Summary
Not yet available
Supplemental Study Information
Not yet available